BioNTech SE
Biotechnology / ImmunotherapyFounded 2008- Updated July 2025
Reviewed by Swet Parvadiya
Last reviewed: July 2025
CorpDigest
BioNTech SE
Annual Revenue
Last reviewed: 2025-07-15 · By Swet Parvadiya
FY2024 Revenue
$3.0B
▼ 27.9% vs FY2023 ($4.2B)
BioNTech SE reported $3.0B in revenue for fiscal year 2024. This represents a decline of 27.9% compared to the 2023 figure of $4.2B. In 2025, revenue increased to $3.2B.
Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.